Huot, Philippe <br/><br/>
Anatomically selective serotonergic type 1A and serotonergic type 2A therapies for Parkinson's disease: an approach to reducing dyskinesia without exacerbating parkinsonism?  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Oct 2011 
 - 2-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1521-0103 
<br/><br/><label>Standard No.: </label>10.1124/jpet.111.184093  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antiparkinson Agents--pharmacology<br/>Dyskinesia, Drug-Induced--drug therapy<br/>Humans<br/>MPTP Poisoning--drug therapy<br/>Parkinson Disease--drug therapy<br/>Receptor, Serotonin, 5-HT1A--drug effects<br/>Receptor, Serotonin, 5-HT2A--drug effects<br/>Serotonin Agents--pharmacology<br/>Synaptic Transmission--drug effects